BioSpace News Archive

Today, Trevi announced financial results for the quarter and year ended December 31, 2021, as well as provided business updates.

Amneal Pharmaceuticals, Inc. announced it has been awarded a sub-license from the Medicines Patent Pool to manufacture and commercialize a generic version of nirmatrelvir, co-packaged with ritonavir, in 95 low- and middle-income countries.

Kezar Life Sciences, Inc., (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided a business update.

Viveve Medical, Inc., a medical technology company focused on women’s intimate health, reported financial results for the year ended December 31, 2021.

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing its DeltEx platform, today announced financial results and operational highlights for the fourth quarter and full-year ending December 31, 2021.

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on its operational progress for the fourth quarter and year ended December 31, 2021.

Medpace Holdings, Inc. announced that it will report its first quarter 2022 financial results after the market close on Monday, April 25, 2022.

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today provided a corporate update and reported financial results for the fourth quarter and year ended December 31, 2021.

The evidence is clear that the COVID-19 pandemic has contributed to a worsening of the overdose crisis, which continues to affect individuals, families and communities across Canada every single day.

IntelGenx Technologies Corp., a leader in pharmaceutical films, announced that it will release its fourth quarter and full year 2021 financial results after market close on Thursday, March 24, 2022.